Repurposing ibuprofen-loaded microemulsion for the management of Alzheimer’s disease: evidence of potential intranasal brain targeting

References

• Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L. (2010). Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals 3:1949–64.
   Google Scholar
• Alany RG, El Maghraby G, Krauel-Goellner K, Graf A. (2008). Microemulsion systems and their potential as drug carrier. In: Fanum M, ed. Microemulsions: properties and applications. London: CRC Press, 247.
   Google Scholar
• Alany RG, Rades T, Agatonovic-Kustrin S, et al. (2000). Effects of alcohols and diols on the phase behaviour of quaternary systems. Int J Pharm 196:141–5.(99)00408-1.
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association, Medications for Memory Loss | Alzheimer’s Association. (2019). https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory [last accessed 7 May 2020].
   Google Scholar
• Alzheimer’s Association. (2019). Alzheimer’s disease facts and figures. Alzheimer’s Dement 15:321–87.
   Web of Science ®Google Scholar
• Appleby BS, Nacopoulos D, Milano N, et al. (2013). A review: treatment of Alzheimer’s disease discovered in repurposed agents. Dement Geriatr Cogn Disord 35:1–22.
   PubMed Web of Science ®Google Scholar
• Bhattamisra SK, Shak AT, Xi LW, et al. (2020). Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson’s disease. Int J Pharm 579:119148.
   PubMed Web of Science ®Google Scholar
• Bitter C, Suter-Zimmermann K, Surber C. (2011). Nasal drug delivery in humans. Curr Probl Dermatol 40:20–35.
   PubMedGoogle Scholar
• Boron WF, Boulpaep EL. (2016). Medical physiology: a cellular and molecular approach. 3rd ed. Philadelphia (PA): Elsevier. https://www.worldcat.org/title/medical-physiology-a-cellular-and-molecular-approach/oclc/190860094 [last accessed 20 Feb 2021].
   Google Scholar
• British Pharmacopoeia Commission. (2013). British pharmacopoeia 2013. London: Stationery Office.
   Google Scholar
• Center for Drug Evaluation and Research. (1995). Q2(R1) validation of analytical procedures: text and methodology. https://doi.org/10.32388/yokp53.
   Google Scholar
• Cole GM, Frautschy SA. (2012). Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimers disease. CNS Neurol Disord - Drug Targets 9:140–8.
   Web of Science ®Google Scholar
• Combs CK, Johnson DE, Karlo JC, et al. (2000). Inflammatory mechanisms in Alzheimer’s disease: inhibition of β- amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J Neurosci 20:558–67.
   PubMed Web of Science ®Google Scholar
• Cummings J, Aisen PS, Dubois B, et al. (2016). Drug development in Alzheimer’s disease: the path to 2025. Alzheimer’s Res Ther 8:39.
   PubMed Web of Science ®Google Scholar
• Dill J, Patel AR, Yang XL, et al. (2010). A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons. J Neurosci 30:963–72.
   PubMed Web of Science ®Google Scholar
• Djordjevic L, Primorac M, Stupar M. (2005). In vitro release of diclofenac diethylamine from caprylocaproyl macrogolglycerides based microemulsions. Int J Pharm 296:73–9.
   PubMed Web of Science ®Google Scholar
• Dow Chemicals, Propylene Glycol. (2014). http://msdssearch.dow.com/PublishedLiteratureDOWCOM/dh_0917/0901b8038091745a.pdf?filepath=propyleneglycol/pdfs/noreg/117-17105.pdf&fromPage=GetDoc.
   Google Scholar
• Eisai and Biogen. (2019). Discontinue phase III clinical studies of BACE inhibitor Elenbecestat in early Alzheimer’s disease [Press Release], 1–3. https://www.prnewswire.com/news-releases/eisai-and-biogen-to-discontinue-phase-iii-clinical-studies-of-bace-inhibitor-elenbecestat-in-early-alzheimers-disease-300917734.html [last accessed 30 Apr 2020].
   Google Scholar
• Escada P. (2013). [Localization and distribution of human olfactory mucosa in the nasal cavities]. Acta Med Port 26:200–7.
   PubMed Web of Science ®Google Scholar
• FDA, GRAS Substances (SCOGS) Database. (2018). https://www.accessdata.fda.gov/scripts/fdcc/?set=SCOGS [last accessed 11 May 2020].
   Google Scholar
• Fu Q, Hue J, Li S. (2007). Nonsteroidal anti-inflammatory drugs promote axon regeneration via RhoA inhibition. J Neurosci 27:4154–64.
   PubMed Web of Science ®Google Scholar
• Ha E, Wang W, Wang YJ. (2002). Peroxide formation in polysorbate 80 and protein stability. J Pharm Sci 91:2252–64.
   PubMed Web of Science ®Google Scholar
• Haider MF, Khan S, Gaba B, et al. (2018). Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation. J Mol Liq 255:384–96.
   Web of Science ®Google Scholar
• Hensley K. (2010). Neuroinflammation in Alzheimer’s disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J Alzheimer’s Dis 21:14.
   Web of Science ®Google Scholar
• Illum L. (2003). Nasal drug delivery - possibilities, problems and solutions. J Control Release 87:187–98.(02)00363-2.
   PubMed Web of Science ®Google Scholar
• Imbimbo BP, Solfrizzi V, Panza F. (2010). Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment? Front Aging Neurosci 2:1–14.
   PubMed Web of Science ®Google Scholar
• in t’ Veld BA, Ruitenberg A, Hofman A, et al. (2001). Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 345:1515–21.
   PubMed Web of Science ®Google Scholar
• Jain JM, Fernandes C, Patravale C. (2010). Formulation development of parenteral phospholipid-based microemulsion of etoposide. AAPS PharmSciTech 11:826–31.
   PubMed Web of Science ®Google Scholar
• Jojo GM, Kuppusamy G. (2019). Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer’s disease. J Clin Pharm Ther 44:337–48.
   PubMed Web of Science ®Google Scholar
• Kerwin BA. (2008). Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci 97:2924–35.
   PubMed Web of Science ®Google Scholar
• Kia’I N, Bajaj T. (2019). Histology, respiratory epithelium. Treasure Island (FL): StatPearls Publishing. http://www.ncbi.nlm.nih.gov/pubmed/31082105 [last accessed 6 March 2021].
   Google Scholar
• Kilkenny C, Browne WJ, Cuthill IC, et al. (2010). Improving bioscience research reporting: The arrive guidelines for reporting animal research. PLoS Biol 8:e1000412–2.
   PubMed Web of Science ®Google Scholar
• Kommuru TR, Gurley B, Khan MA, Reddy IK. (2001). Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 212:233–46.(00)00614-1.
   PubMed Web of Science ®Google Scholar
• Laine L. (2003). Perspectives in pain management: the role of coxibs gastrointestinal effects of NSAIDs and Coxibs, S32. J Pain Symptom Manag 25:32–40.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121.(00)00103-4.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. (2012). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 64:175–93.
   Web of Science ®Google Scholar
• Li J, Guo R, Hu H, et al. (2018). Preparation optimisation and storage stability of nanoemulsion-based lutein delivery systems. J Microencapsul 35:570–83.
   PubMed Web of Science ®Google Scholar
• Li L, Nandi I, Kim KH. (2002). Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int J Pharm 237:77–85.(02)00029-7.
   PubMed Web of Science ®Google Scholar
• Mahajan HS, Mahajan MS, Nerkar PP, Agrawal A. (2014). Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting. Drug Deliv 21:148–54.
   PubMed Web of Science ®Google Scholar
• Mandal S, Das Mandal S, Chuttani K, et al. (2018). Preclinical study of ibuprofen loaded transnasal mucoadhesive microemulsion for neuroprotective effect in MPTP mice model. Iran J Pharm Res 17:23–38. https://doi.org/10.22037/ijpr.2018.2169.
   PubMed Web of Science ®Google Scholar
• Mandrekar-Colucci S, Landreth GE. (2012). Microglia and inflammation in Alzheimer’s disease. CNS Neurol Disord Drug Targets 9:156–67.
   Web of Science ®Google Scholar
• Manev ED, Pugh RJ. (1991). Diffuse layer electrostatic potential and stability of thin aqueous films containing a nonionic surfactant*. Langmuir 7:2253–60.
   Web of Science ®Google Scholar
• McGeer PL, Guo JP, Lee M, et al. (2018). Alzheimer’s disease can be spared by nonsteroidal anti-inflammatory drugs. J Alzheimer’s Dis 62:1219–22.
   PubMed Web of Science ®Google Scholar
• Mehta SK, Kaur G, Bhasin KK. (2010). Tween-embedded microemulsions-physicochemical and spectroscopic analysis for antitubercular drugs. AAPS PharmSciTech 11:143–53.
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Anissimov YG, Bunge AL, et al. (2011). Mathematical models of skin permeability: an overview. Int J Pharm 418:115–29.
   PubMed Web of Science ®Google Scholar
• Moore AH, Bigbee MJ, Boynton GE, et al. (2010). Non-steroidal anti-inflammatory drugs in Alzheimer’s disease and Parkinson’s disease: reconsidering the role of neuroinflammation. Pharmaceuticals 3:1812–41.
   Google Scholar
• Moulik SP, Paul BK. (1998). Structure, dynamics and transport properties of micro emulsions. Adv Colloid Interface Sci 78:99–195.(98)00063-3.
   Web of Science ®Google Scholar
• Ngawhirunpat T, Worachun N, Opanasopit P, et al. (2013). Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen. Pharm Dev Technol 18:798–803.
   PubMed Web of Science ®Google Scholar
• Panapisal V, Charoensri S, Tantituvanont A. (2012). Formulation of microemulsion systems for dermal delivery of silymarin. AAPS PharmSciTech 13:389–99.
   PubMed Web of Science ®Google Scholar
• Patel RB, Mrunali Patel BR, Kashyap Bhatt BK, Bharat Patel BG. (2013). Formulation and evaluation of microemulsions-based drug delivery system for intranasal administration of olanzapine. Int J Biomed Pharm Sci 7:20–7.
   Google Scholar
• Patel RB, Patel MR, Bhatt KK, Patel BG. (2013). Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine. Bull Fac Pharm Cairo Univ 51:243–53.
   Google Scholar
• Patterson C. (2018). World Alzheimer report 2018. The state of the art of dementia research: new frontiers. London (UK): Alzheimer’s Disease International.
   Google Scholar
• Perry C, Mackay-sim A, Feron F, Mcgrath J. (2002). Olfactory neural cells: an untapped diagnostic and therapeutic resource. The 2000 Ogura Lecture. Laryngoscope. 112:603–7.
   PubMed Web of Science ®Google Scholar
• Prieto C, Calvo L. (2013). Performance of the biocompatible surfactant tween 80, for the formation of microemulsions suitable for new pharmaceutical processing. J Appl Chem 2013:1–10.
   Google Scholar
• Reekmans S, Luo H, Van der Auweraer M, De Schryver FC. (1990). Influence of alcohols and alkanes on the aggregation behavior of ionic surfactants in water. Langmuir 6:628–37.
   Web of Science ®Google Scholar
• Restu WK, Sampora Y, Meliana Y, Haryono A. (2015). Effect of accelerated stability test on characteristics of emulsion systems with chitosan as a stabilizer. Procedia Chem 16:171–6.
   Google Scholar
• Rey NL, Wesson DW, Brundin P. (2018). The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis 109:226–48.
   PubMed Web of Science ®Google Scholar
• Schettler D, Paris T, Pellett S, et al. (2001). Comparative pharmacokinetics of two fast-dissolving oral ibuprofen formulations and a regular-release ibuprofen tablet in healthy volunteers. Clin Drug Investig 21:73–8.
   Web of Science ®Google Scholar
• Sekiyama K, Fujita M, Sekigawa A, et al. (2012). Ibuprofen ameliorates protein aggregation and astrocytic gliosis, but not cognitive dysfunction, in a transgenic mouse expressing dementia with Lewy bodies-linked P123H β-synuclein. Neurosci Lett 515:97–101.
   PubMed Web of Science ®Google Scholar
• Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, et al. (2007). Formulation development and optimization using nanoemulsion technique: a technical mote. AAPS PharmSciTech 8:E12–7.
   PubMed Web of Science ®Google Scholar
• Sheskey PJ, Hancock BC, Moss GP, Goldfarb DJ. (2020). Handbook of pharmaceutical excipients. 9th ed. London: Pharmaceutical Press.
   Google Scholar
• Shoaib M, Kamal MA, Danish Rizvi SM. (2017). Repurposed drugs as potential therapeutic candidates for the management of Alzheimer’s disease. Curr Drug Metab 18:842–52.
   PubMed Web of Science ®Google Scholar
• Singh AK, Singh A, Madhv NS. (2012). Nasal cavity, a promising transmucosal platform for drug delivery and research approaches from nasal to brain targetting. J Drug Deliv Ther 2:22.
   Google Scholar
• Sintov AC, Botner S. (2006). Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm 311:55–62.
   PubMed Web of Science ®Google Scholar
• Sohraby F, Bagheri M, Aryapour H. (1903/2019). Performing an in silico repurposing of existing drugs by combining virtual screening and molecular dynamics simulation. Methods Mol Biol 1903:23–43.
   Google Scholar
• Swarbrick J. (2013). Emulsions and microemulsions. In: Encyclopedia of pharmaceutical technology. 3rd ed. Boca Raton (FL): Taylor & Francis, 1548.
   Google Scholar
• Szekely CA, Breitner JCS, Fitzpatrick AL, et al. (2008). NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology 70:17–24.
   PubMed Web of Science ®Google Scholar
• Szumała P. (2015). Structure of microemulsion formulated with monoacylglycerols in the presence of polyols and ethanol. J Surfactants Deterg 18:97–106.
   PubMed Web of Science ®Google Scholar
• Tashtoush BM, Bennamani AN, Al-Taani BM. (2013). Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery. Pharm Dev Technol 18:834–43.
   PubMed Web of Science ®Google Scholar
• Turner PV, Brabb T, Pekow C, Vasbinder MA. (2011). Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 50:600–13.
   PubMed Web of Science ®Google Scholar
• Venkatachalam S, Jaiswal A, De A, Vijayakumar RK. (2019). Repurposing drugs for management of Alzheimer disease. Res J Pharm Technol 12:3078–88.
   Google Scholar
• Wen MM, El-Kamel AH, Khalil SA. (2012). Systemic enhancement of papaverine transdermal gel for erectile dysfunction. Drug Dev Ind Pharm 38:912–22.
   PubMed Web of Science ®Google Scholar
• Wen MM. (2011). Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain — current development. Discov Med 11:497–503.
   PubMed Web of Science ®Google Scholar
• Winsor PA. (1948). Hydrotropy, solubilisation and related Emulsification processes. Part I. Trans Faraday Soc 44:376–98.
   Google Scholar
• World Health Organization (WHO) (2019). World health organization model list of essential medicines. Ment Holist Heal Some Int Perspect 119–34.
   Google Scholar
• Xie Y, Lu W, Cao SC, et al. (2006). Preparation of bupleurum nasal spray and evaluation on its safety and efficacy. Chem Pharm Bull (Tokyo) 54:48–53.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–71.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang L, Meng L, et al. (2013). Design and evaluation of a self-microemulsifying drug delivery system for apigenin. Drug Dev Ind Pharm 39:662–9.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Su Y, Li B, et al. (2003). Nonsteroidal anti-inflammatpry drugs can lower amyloidogenic Aβ 42 by inhibiting Rho. Science 302:1215–7.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Sun B, Guo J, Zhou G. (2020). Intranasal injection of recombinant human erythropoietin improves cognitive and visual impairments in chronic cerebral ischemia rats. Biomed Rep 13:1–7.
   PubMed Web of Science ®Google Scholar